... citrate reduces intravenous iron and erythropoiesis-stimulating agent use in ESRD . J Am Soc Nephrol . 2015 ; 26 ( 10 ): 2578 – 87 . 10. Lewis JB , Sika M , Koury MJ , Chuang P , Schulman G , Smith MT , . Ferric citrate controls phosphorus and delivers iron...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Anaemia Chronic kidney disease Intravenous iron Iron deficiency Ferric derisomaltose...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Anemia Chronic kidney disease Hemodialysis Intravenous iron Iron sucrose Since the introduction of erythropoiesis-stimulating agents (ESAs) for the management of anemia...

... of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Intravenous iron...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Intravenous iron Free iron Staphylococcus aureus infection Vascular access Infection is the second leading...

...Robert Landry; Paula M. Jacobs; Robert Davis; Magdy Shenouda; W. Kline Bolton Background: Currently available intravenous iron preparations are not ideal, either because of safety concerns or dose limitations. We investigated the safety and pharmacokinetics of ferumoxytol, a new iron replacement...